Articles by Sally Anliker - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Sally Anliker

Sally Anliker


Sally Anliker is the director of regulatory affairs CMC at Eli Lilly and Company

Articles
Quality by Design for Biotechnology Products—Part 3
January 1, 2010

Regulatory flexibility can make continuous improvement possible.

Quality by Design for Biotechnology Products—Part 2
December 1, 2009

Second in a three-part series that discusses the complexities of QbD implementation in biotech development.

Quality by Design for Biotechnology Products—Part 1
November 1, 2009

First in a three-part series that discusses the complexities of QbD implementation in biotech product development.

ADVERTISEMENT

ADVERTISEMENT

Click here